China Pharma Holdings CPHI
NYSE CPHI
$0.67 -0.05 (-6.91%)
As of: Sep 29, 2026 · 3:57 PM EDT

China Pharma Holdings (CPHI) Convertible Debt (2021 - 2022)

Updated

China Pharma Holdings (CPHI) reported Convertible Debt of $4.75 million for Q2 2022, down 4.0% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Convertible Debt (2021 - 2022) Analysis & Trends

At the end of FY2021, China Pharma Holdings posted Convertible Debt of $5.25 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 China Pharma Holdings 29.58 Mn 28.46 Mn 83,566.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 4.75 Mn
Mar 31, 2022 4.95 Mn
Dec 31, 2021 5.25 Mn
API Access

China Pharma Holdings Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CPHI&period=max&api_key=YOUR_API_KEY